Efficacy and safety of percutaneous @entity384 to prevent progression of banding site XXXX after bilateral pulmonary artery banding.

@entity1 @entity384 @entity1699 @entity26 @entity472 @entity397 @entity661 @entity850
OBJECTIVES: To investigate the efficacy and safety of percutaneous @entity384 (PTBD) for the treatment of bilateral pulmonary artery banding (bil-PAB) site @entity850 . Background: Although bil-PAB is an alternative initial treatment for high-risk neonates with @entity1699 ( @entity1699 ) or critical @entity472 (cAS), those @entity1 often suffer from desaturation because of progressive @entity850 of the bil-PAB sites during the interstage period. METHODS: We retrospectively evaluated the efficacy and safety of 11 consecutive PTBD procedures performed between 2006 and 2012 to treat bil-PAB site @entity850 in four high-risk @entity1 (three females) with @entity1699 or cAS. RESULTS: PTBD was repeated twice in two @entity1 and three times in one @entity1 over intervals. The mean @entity661 ( @entity661 ) and @entity661 -to-band circumference (BC) ratio were 3.1        0.5 mm and 0.31        0.06, respectively. After the procedures, the mean minimum lumen diameter was dilated significantly from 1.1        0.1 mm to 1.7        0.3 mm (P   <   0.01), and the mean peripheral @entity26 saturation increased significantly from 75        8% to 85        4% (P   <   0.01). All @entity1 reached the next stage operation involving the Norwood _ bidirectional Glenn or Ross procedure, after growth. No complications such as band @entity397 occurred. CONCLUSIONS: For progressive @entity850 of bil-PAB sites, PTBD using a balloon size that did not exceed the BC ( @entity661 around 30% of the BC) was an effective and safe procedure.    2015 Wiley Periodicals, Inc.
